Enquiry Now
Loading...
| A03267 | Pages: NA | Aug 2021 | 4437 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Methadone Market
Request Now !Methadone is an opioid medication utilized for the treatment of pain and as maintenance therapy. The medication helps to reduce cravings and withdrawal symptoms in people with opioid addiction. In addition, it helps to block the high sensation in parts of the brain and spinal cord that are caused by using opiates. Methadone helps to manage additions in patient dependent to heroin, morphine, or prescription painkillers. It can be used for a short or long duration depending on the requirement of the patient.
Rise in the number of people addicted to various opioid such as heroin and morphine is a major driving factor of the market. Moreover, increase in awareness towards the use of this medication and rise in number of people seeking help to detox boost the market growth. In addition, as the medication can be used for pain management, rise in the number of people with chronic pain is expected to increase the demand for methadone. However, the side effects associated with the use of methadone restrain the market growth.
The global methadone market is segmented based on mode of administration, application, and geography. Based on mode of administration, the market is classified into oral medicine and injections. Oral medicine is further bifurcated into tablets and liquid. Based on application, the market is categorized into operation, detoxification, and other. Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Qinghai Pharm, Roxane (Boehringer Ingelheim), CentralPharm, Mallinckrodt, Macfarlan Smith, VistaPharm, Diskets, Methadoes, Aurolife Pharma LLC, and Dolophine are provided in this report.
Key Benefits
CHAPTER 1INTRODUCTION
1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENTS
1.4.RESEARCH METHODOLOGY
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2EXECUTIVE SUMMARY
2.1.CXO PERSPECTIVE
CHAPTER 3MARKET OVERVIEW
3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.MARKET SHARE ANALYSIS, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.4.1.MARKET DYNAMICS
3.4.2.Drivers
3.4.3.Restraints
3.4.4.Opportunities
CHAPTER 4METHADONE MARKET, BY MODE OF ADMINISTRATION
4.1.OVERVIEW
4.1.1.Market size and forecast
4.2.ORAL MEDICINE
4.2.1.Key market trends
4.2.2.Growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Tablets
4.2.5.Liquid
4.3.INJECTIONS
4.3.1.Key market trends
4.3.2.Growth factors and opportunities
4.3.3.Market size and forecast
CHAPTER 5METHADONE MARKET, BY APPLICATION
5.1.OVERVIEW
5.1.1.Market size and forecast
5.2.OPERATION
5.2.1.Market size and forecast
5.3.DETOXIFICATION
5.3.1.Market size and forecast
5.4.OTHERS
5.4.1.Market size and forecast
CHAPTER 6METHADONE MARKET, BY GEOGRAPHY
6.1.OVERVIEW
6.2.NORTH AMERICA
6.2.1.Key market trends
6.2.2.Key growth factors and opportunities
6.2.3.Market size and forecast
6.2.3.1.U.S. market size and forecast
6.2.3.2.Canada market size and forecast
6.2.3.3.Mexico market size and forecast
6.2.4.North America Methadone Market by Mode of Administration
6.2.5.North America Methadone Market by Application
6.3.EUROPE
6.3.1.Key market trends
6.3.2.Key growth factors and opportunities
6.3.3.Market size and forecast
6.3.3.1.Germany market size and forecast
6.3.3.2.France market size and forecast
6.3.3.3.UK market size and forecast
6.3.3.4.Italy market size and forecast
6.3.3.5.Spain market size and forecast
6.3.3.6.Rest of Europe market size and forecast
6.3.4.Europe Methadone Market by Mode of Administration
6.3.5.Europe Methadone Market by Application
6.4.ASIA-PACIFIC
6.4.1.Key market trends
6.4.2.Key growth factors and opportunities
6.4.3.Market size and forecast
6.4.3.1.Japan market size and forecast
6.4.3.2.China market size and forecast
6.4.3.3.Australia market size and forecast
6.4.3.4.India market size and forecast
6.4.3.5.South Korea market size and forecast
6.4.3.6.Taiwan market size and forecast
6.4.3.7.Rest of Asia-Pacific market size and forecast
6.4.4.Asia-Pacific Methadone Market by Mode of Administration
6.4.5.Asia-Pacific Methadone Market by Application
6.5.LAMEA
6.5.1.Key market trends
6.5.2.Key growth factors and opportunities
6.5.3.Market size and forecast
6.5.3.1.Brazil market size and forecast
6.5.3.2.Turkey market size and forecast
6.5.3.3.Saudi Arabia market size and forecast
6.5.3.4.South Africa market size and forecast
6.5.3.5.Rest of LAMEA market size and forecast
6.5.4.LAMEA Methadone Market by Mode of Administration
6.5.5.LAMEA Methadone Market by Application
CHAPTER 7COMPANY PROFILES
7.1.QINGHAI PHARM
7.1.1.Operating business segments
7.1.2.Business performance
7.1.3.Key strategic moves and developments
7.2.ROXANE (BOEHRINGER INGELHEIM)
7.2.1.Operating business segments
7.2.2.Business performance
7.2.3.Key strategic moves and developments
7.3.CENTRALPHARM
7.3.1.Operating business segments
7.3.2.Business performance
7.3.3.Key strategic moves and developments
7.4.MALLINCKRODT
7.4.1.Operating business segments
7.4.2.Business performance
7.4.3.Key strategic moves and developments
7.5.MACFARLAN SMITH
7.5.1.Operating business segments
7.5.2.Business performance
7.5.3.Key strategic moves and developments
7.6.VISTAPHARM
7.6.1.Operating business segments
7.6.2.Business performance
7.6.3.Key strategic moves and developments
7.7.DISKETS
7.7.1.Operating business segments
7.7.2.Business performance
7.7.3.Key strategic moves and developments
7.8.METHADOES
7.8.1.Operating business segments
7.8.2.Business performance
7.8.3.Key strategic moves and developments
7.9.AUROLIFE PHARMA LLC
7.9.1.Operating business segments
7.9.2.Business performance
7.9.3.Key strategic moves and developments
7.10.DOLOPHINE
7.10.1.Operating business segments
7.10.2.Business performance
7.10.3.Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
